Equilibrium Kp Data and Sampling-Time Pitfalls

Why a Tissue-to-Plasma Ratio Depends on When and How It Is Measured

A measured tissue-to-plasma concentration ratio is not automatically an equilibrium partition coefficient. Tissue and plasma concentrations can change at different rates after a dose, and a tissue sample can contain blood that was still present when the tissue was collected. Even when the measurements are otherwise sound, the numerator and denominator may use different concentration bases. Each issue can shift the ratio without any change in the underlying equilibrium partitioning.

The key question is therefore not simply, “What is the ratio?” It is, “Do these matched measurements represent a stable distribution relationship, and have they been placed on compatible concentration bases?” The answer depends on the sampling design, the concentration time courses, and the treatment of residual blood.

In an organism receiving drug, “equilibrium” is usually an operational term: concentrations are stable enough, over the relevant interval and under the relevant input conditions, that the tissue-to-plasma ratio is no longer changing materially. It does not mean the whole organism is a closed system at thermodynamic equilibrium. A ratio based on a transient sample can still be calculated, but it should be described as a time-specific observed ratio rather than assumed to be an equilibrium \(K_p\).

Reading a Distribution Time Course

The most informative evidence about sampling time comes from matched tissue and plasma measurements at more than one time. A useful design holds the dosing or infusion conditions constant long enough to observe whether concentrations approach plateaus and whether their ratio becomes stable. If plasma changes rapidly while tissue accumulates more slowly, an early tissue-to-plasma ratio may be smaller than the eventual ratio. In other circumstances, tissue can decline more slowly than plasma and the ratio may rise after plasma has begun to fall.

For a time-varying concentration profile, calculate the ratio at each matched time, \(R(t)=C_T(t)/C_P(t)\), after putting both concentrations on compatible bases. A stable ratio across late samples is evidence for an operational equilibrium estimate only when the underlying measurements are also sufficiently stable and the sampling interval is appropriate. A flat ratio alone is not decisive: both concentrations could still be changing proportionally, or sparse sampling could miss important changes.

A changing plasma concentration makes interpretation harder. After a bolus dose, for example, a tissue concentration may lag behind plasma during the distribution phase. Later, plasma may decline faster than tissue, so the ratio can increase even if tissue concentration is also declining. A ratio from one time point can therefore reflect the direction and speed of distribution, not just the tissue’s eventual partitioning. In a changing-concentration setting, paired time courses are more informative than treating one sample as a steady-state measurement.

Residual Blood in a Tissue Sample

A tissue homogenate may include blood remaining in the tissue vasculature at collection. If the drug concentration in that blood differs from the concentration in the tissue outside the vascular space, the measured tissue concentration combines two contributions. When the blood concentration is high, this contribution can inflate the apparent tissue concentration; when it is low, it can reduce it.

A simple volume-mixture correction makes the assumptions explicit. Let \(v_b\) be the fraction of the sampled tissue volume occupied by residual blood, \(C_{T,meas}\) the measured tissue concentration, \(C_b\) the drug concentration in that residual blood, and \(C_{T,corr}\) the estimated concentration in the non-blood tissue volume. Assuming a two-compartment volume mixture and representative concentration measurements:

Rearranging gives:

This correction is only as reliable as its inputs and assumptions. It treats \(v_b\) as known, assumes the blood concentration represents the blood remaining in the sampled tissue, and assumes the measurement is a simple volume-weighted mixture. It does not automatically account for incomplete recovery, tissue processing effects, or differences between sampled and unsampled regions. A correction should not be presented as exact when its inputs are uncertain.

Normalize Concentrations Before Dividing

A ratio is interpretable only when the concentration bases are compatible. For example, tissue concentration may be reported as mass of drug per mass of tissue, while plasma concentration is mass of drug per volume of plasma. Dividing the numerical values directly does not yield a dimensionless volume-to-volume \(K_p\); the result retains units. Either report the ratio with those units or convert one concentration using an explicitly stated tissue density or other justified conversion.

Normalization also requires care about what the tissue measurement represents. Concentrations per gram of wet tissue, per gram of dry tissue, per tissue volume, and per amount of tissue water are not interchangeable. The chosen basis should match the definition used for the intended comparison. Do not silently treat a mass-based tissue concentration as a volume-based one.

Evidence, Alternatives, and Failure Modes

A single terminal sample is often practical and may be the only available measurement. It can provide a time-specific tissue-to-plasma ratio, but by itself it cannot demonstrate that the ratio has stabilized. A time-course design can reveal approach to a plateau and is generally stronger evidence for an equilibrium estimate, though it requires more samples and still depends on appropriate sampling intervals. Perfusing tissue before collection can reduce vascular contribution, but perfusion may alter tissue concentrations or remove drug from compartments that are part of the intended measurement. A model-based correction for residual blood can be useful when direct removal is unsuitable, but it relies on assumptions and measured inputs. These approaches answer related, not identical, questions; none makes timing and concentration normalization irrelevant.

Useful diagnostics include plotting paired tissue and plasma concentrations against time, inspecting the ratio over time, checking whether late concentrations or ratios continue to drift, and verifying that units and sample-processing procedures are consistent. When replicates are available, their spread also helps show whether an apparent plateau is larger than the measurement variability. A ratio that changes systematically across late time points, or whose value depends strongly on whether an uncorrected or corrected tissue concentration is used, warrants cautious interpretation.

Several limitations remain even with a stable-looking time course. Sparse sampling can miss a transient phase; variable dosing or sampling can undermine comparisons; and a single tissue sample may not represent the whole organ. A stable ratio in one experimental condition does not guarantee the same ratio under another dosing regimen, concentration range, species, or physiological state. In reporting, state the sampling time or interval, the basis of each concentration, whether residual blood was addressed, and why the data were judged to support—or not support—an equilibrium estimate.